doi: 10.1056/NEJMoa2028395
These variations significantly influence the role of GLP-1 in regulating islet function and glucose homeostasis
According to clinical trials, prescription GLP-1 medications typically lead to 518% weight loss, while studies of high-dose tirzepatide combined with intensive lifestyle support have reported reductions of up to ~25%
Two days after plating, various concentrations of glucose, DCA, triplete, and 007-AM in modified Ringer buffer (RB: 140 mM NaCl, 3.5 mM KCl, 0.5 mM NaH 2 PO 4 , 1.5 mM CaCl 2 , 10-mM HEPES, and 2-mM NaHCO 3 ) containing DPP-4 inhibitor (25 M) and 0.5% (v/v) BSA were administered to the cells, which were then incubated for 2 h
Most individuals can expect the following outcomes: Its important to remember that GLP-1 therapy is not a quick fix
Research confirms that these side effects are dose-dependent, meaning the higher the dose, the sicker you are likely to feel